Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348634 · ClinicalTrials.gov registry record · Phase 4
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
A Phase 4 study, sponsored by Novartis.
- Terminated
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00348634 is a Phase 4 study that was terminated before completion, run by Novartis. The registered enrollment target is 60 participants.
The verdict
NCT00348634, a Phase 4 study, was terminated before completion, sponsored by Novartis.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.
Interventions
- DRUG Tegaserod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348634
The ClinicalTrials.gov registry entry for NCT00348634 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tegaserod is the first listed.
NCT00348634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00348634 about?
NCT00348634 is a clinical study titled "Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients". This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.
What is the current status of trial NCT00348634?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2006-07. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00348634?
The interventions under investigation include: Tegaserod (DRUG).
Who is sponsoring clinical trial NCT00348634?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.